Howard Hughes Medical Institute’s KLA KLAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.69M Buy
18,250
+17,970
+6,418% +$2.63M 0.65% 21
2025
Q4
$34K Hold
280
0.02% 70
2025
Q3
$30.2K Hold
280
0.02% 81
2025
Q2
$25.1K Buy
+280
New +$21.1K 0.01% 89

Other funds holding KLAC

Howard Hughes Medical Institute's KLAC Position: Q1 2026 in Review

Howard Hughes Medical Institute increased its KLA (KLAC) stake by 6,418% in Q1 2026, buying an estimated $2.63M and bringing the position to 18,250 shares worth $2.69M. The position accounts for 0.65% of the portfolio, ranked #21.

Howard Hughes Medical Institute first reported a position in KLAC in Q2 2025 and has held it in 4 quarters since. 2,064 funds tracked by Wall St. Rank hold KLAC as of Q1 2026.

  • Howard Hughes Medical Institute held 18,250 shares of KLA worth $2.69M as of Q1 2026.
  • Howard Hughes Medical Institute bought 17,970 KLA shares in Q1 2026, an estimated $2.63M.
  • KLA made up 0.65% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #21 holding.
  • Howard Hughes Medical Institute first reported a position in KLA in Q2 2025 and has held it in 4 quarters since.
  • 2,064 funds tracked by Wall St. Rank held KLA as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.